0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Injection Pens Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-23N8719
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetes Injection Pens Market Outlook 2022
BUY CHAPTERS

Global Diabetes Injection Pens Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-23N8719
Report
July 2025
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diabetes Injection Pens Market Size

In 2024, the global market size of Diabetes Injection Pens was estimated to be worth US$ 5133 million and is forecast to reach approximately US$ 7674 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.

Diabetes Injection Pens Market

Diabetes Injection Pens Market

Diabetes injection pens are convenient devices used for the self-administration of insulin and other diabetes medications. The pens are designed with a built-in cartridge and needle, providing an easy and accurate way for patients to inject their medication. They are widely preferred due to their ease of use, discreetness, and ability to ensure precise dosage control.
These pens are available in both reusable and disposable versions, and some advanced models include features like adjustable dose settings, digital tracking, and memory functions to help patients monitor and manage their treatment regimen more effectively. The development of insulin pens has greatly improved the quality of life for diabetic patients, making diabetes management simpler and more efficient.
Market Drivers for Diabetes Injection Pens
Rising Prevalence of Diabetes: The increasing global incidence of diabetes, driven by aging populations, sedentary lifestyles, and unhealthy diets, fuels demand for injection pens.
Convenience and Ease of Use: Injection pens offer precise dosing, portability, and user-friendly features, making them highly popular among patients compared to traditional syringes.
Technological Advancements: Innovations such as smart pens with digital tracking and connectivity to health apps enhance treatment adherence and monitoring.
Increased Awareness and Diagnosis: Growing awareness campaigns and better diagnostic tools are identifying more diabetes cases, boosting demand for insulin delivery devices.
Government Support and Reimbursement Policies: Favorable healthcare policies and insurance coverage for diabetes management encourage the adoption of injection pens.
Market Challenges for Diabetes Injection Pens
High Cost of Devices: Advanced injection pens and associated consumables are often expensive, limiting accessibility for low-income populations.
Limited Awareness in Developing Regions: Inadequate knowledge about diabetes management and availability of injection pens in underdeveloped areas hinder market penetration.
Competition from Alternative Delivery Methods: Technologies such as insulin pumps, oral medications, and non-invasive devices pose a challenge to injection pens.
Environmental Concerns: The disposable nature of many injection pens raises environmental issues due to medical waste.
Patient Reluctance to Injections: Fear of needles or lack of proper training for self-administration can discourage some patients from using injection pens.
Global diabetes injection pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top 1 manufacturer hold a share nearly 50%. Europe is the largest market, with a share over 40%. In terms of product, reusable insulin pens is the largest segment, with a share about 65%. And in terms of application, the largest application is retail pharmacy, followed by hospital and clinic, online sales, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diabetes Injection Pens, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Injection Pens.
The Diabetes Injection Pens market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Injection Pens market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Injection Pens manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Diabetes Injection Pens Market Report

Report Metric Details
Report Name Diabetes Injection Pens Market
CAGR 6.0%
Segment by Type
Segment by Application
  • Hospital & Clinic
  • Retail Pharmacy
  • Online Sales
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Diabetes Injection Pens in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Diabetes Injection Pens manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Injection Pens sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Diabetes Injection Pens Market share by region?

Ans: Europe is the largest market, with a share over 40%.

What is the Diabetes Injection Pens Market share by type?

Ans: In terms of product, reusable insulin pens is the largest segment, with a share about 65%.

Who are the main players in the Diabetes Injection Pens Market report?

Ans: The main players in the Diabetes Injection Pens Market are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu

What are the Application segmentation covered in the Diabetes Injection Pens Market report?

Ans: The Applications covered in the Diabetes Injection Pens Market report are Hospital & Clinic, Retail Pharmacy, Online Sales

What are the Type segmentation covered in the Diabetes Injection Pens Market report?

Ans: The Types covered in the Diabetes Injection Pens Market report are Reusable Insulin Pens, Disposable Insulin Pens

Recommended Reports

Insulin Pen Devices

Insulin Needles & Accessories

Diabetes Drug Delivery

1 Study Coverage
1.1 Diabetes Injection Pens Product Introduction
1.2 Market by Type
1.2.1 Global Diabetes Injection Pens Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Reusable Insulin Pens
1.2.3 Disposable Insulin Pens
1.3 Market by Application
1.3.1 Global Diabetes Injection Pens Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital & Clinic
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diabetes Injection Pens Market Size Estimates and Forecasts
2.1.1 Global Diabetes Injection Pens Revenue 2020-2031
2.1.2 Global Diabetes Injection Pens Sales 2020-2031
2.2 Diabetes Injection Pens Market Size by Region: 2024 Versus 2031
2.3 Diabetes Injection Pens Sales by Region (2020-2031)
2.3.1 Global Diabetes Injection Pens Sales by Region: 2020-2025
2.3.2 Global Diabetes Injection Pens Sales Forecast by Region (2026-2031)
2.3.3 Global Diabetes Injection Pens Sales Market Share by Region (2020-2031)
2.4 Diabetes Injection Pens Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Diabetes Injection Pens Revenue by Region: 2020-2025
2.4.2 Global Diabetes Injection Pens Revenue Forecast by Region (2026-2031)
2.4.3 Global Diabetes Injection Pens Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Diabetes Injection Pens Sales by Type (2020-2031)
3.1.1.1 Global Diabetes Injection Pens Sales Volume by Type (2020-2031)
3.1.1.2 Global Diabetes Injection Pens Sales Market Share by Type (2020-2031)
3.1.2 Global Diabetes Injection Pens Revenue by Type (2020-2031)
3.1.2.1 Global Diabetes Injection Pens Revenue by Type (2020-2031)
3.1.2.2 Global Diabetes Injection Pens Revenue Market Share by Type (2020-2031)
3.1.3 Diabetes Injection Pens Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Diabetes Injection Pens Sales by Application (2020-2031)
3.2.1.1 Global Diabetes Injection Pens Sales Volume by Application (2020-2031)
3.2.1.2 Global Diabetes Injection Pens Sales Market Share by Application (2020-2031)
3.2.2 Global Diabetes Injection Pens Revenue by Application (2020-2031)
3.2.2.1 Global Diabetes Injection Pens Revenue by Application (2020-2031)
3.2.2.2 Global Diabetes Injection Pens Revenue Market Share by Application (2020-2031)
3.2.3 Diabetes Injection Pens Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Reusable Insulin Pens of Diabetes Injection Pens Revenue Market Share by Application
3.3.2 Disposable Insulin Pens of Diabetes Injection Pens Revenue Market Share by Application
4 Global Diabetes Injection Pens by Manufacturers
4.1 Global Top Diabetes Injection Pens Manufacturers by Sales (2020-2025)
4.1.1 Global Diabetes Injection Pens Sales by Manufacturer (2020-2025)
4.1.2 Global Diabetes Injection Pens Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Diabetes Injection Pens Manufacturers by Revenue (2020-2025)
4.2.1 Global Diabetes Injection Pens Revenue by Manufacturer (2020-2025)
4.2.2 Global Diabetes Injection Pens Revenue Share by Manufacturer (2020-2025)
4.3 Global Diabetes Injection Pens Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Diabetes Injection Pens Manufacturers Covered: Ranking by Revenue
4.4.2 Global Diabetes Injection Pens Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Diabetes Injection Pens Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Diabetes Injection Pens Manufacturing Base Distribution, Product Type
4.5.1 Diabetes Injection Pens Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Diabetes Injection Pens Market
4.5.3 Manufacturers Diabetes Injection Pens Product Type and Application
4.5.4 Reusable Insulin Pens Market Sales of Diabetes Injection Pens by Manufacturer
4.5.5 Disposable Insulin Pens Market Sales of Diabetes Injection Pens by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novo Nordisk
5.1.1 Novo Nordisk Company Information
5.1.2 Novo Nordisk Description, Business Overview
5.1.3 Novo Nordisk Diabetes Injection Pens Products Offered
5.1.4 Novo Nordisk Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novo Nordisk Diabetes Injection Pens Sales by Product in 2024
5.1.6 Novo Nordisk Diabetes Injection Pens Sales by Application in 2024
5.1.7 Novo Nordisk Diabetes Injection Pens Sales by Geographic Area in 2024
5.1.8 Novo Nordisk Recent Developments
5.2 Eli Lilly
5.2.1 Eli Lilly Company Information
5.2.2 Eli Lilly Description, Business Overview
5.2.3 Eli Lilly Diabetes Injection Pens Products Offered
5.2.4 Eli Lilly Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Eli Lilly Diabetes Injection Pens Sales by Product in 2024
5.2.6 Eli Lilly Diabetes Injection Pens Sales by Application in 2024
5.2.7 Eli Lilly Diabetes Injection Pens Sales by Geographic Area in 2024
5.2.8 Eli Lilly Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Diabetes Injection Pens Products Offered
5.3.4 Sanofi Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Diabetes Injection Pens Sales by Product in 2024
5.3.6 Sanofi Diabetes Injection Pens Sales by Application in 2024
5.3.7 Sanofi Diabetes Injection Pens Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 BD
5.4.1 BD Company Information
5.4.2 BD Description, Business Overview
5.4.3 BD Diabetes Injection Pens Products Offered
5.4.4 BD Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.4.5 BD Diabetes Injection Pens Sales by Product in 2024
5.4.6 BD Diabetes Injection Pens Sales by Application in 2024
5.4.7 BD Diabetes Injection Pens Sales by Geographic Area in 2024
5.4.8 BD Recent Developments
5.5 Ypsomed Holding
5.5.1 Ypsomed Holding Company Information
5.5.2 Ypsomed Holding Description, Business Overview
5.5.3 Ypsomed Holding Diabetes Injection Pens Products Offered
5.5.4 Ypsomed Holding Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Ypsomed Holding Diabetes Injection Pens Sales by Product in 2024
5.5.6 Ypsomed Holding Diabetes Injection Pens Sales by Application in 2024
5.5.7 Ypsomed Holding Diabetes Injection Pens Sales by Geographic Area in 2024
5.5.8 Ypsomed Holding Recent Developments
5.6 Dongbao
5.6.1 Dongbao Company Information
5.6.2 Dongbao Description, Business Overview
5.6.3 Dongbao Diabetes Injection Pens Products Offered
5.6.4 Dongbao Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Dongbao Diabetes Injection Pens Sales by Product in 2024
5.6.6 Dongbao Diabetes Injection Pens Sales by Application in 2024
5.6.7 Dongbao Diabetes Injection Pens Sales by Geographic Area in 2024
5.6.8 Dongbao Recent Developments
5.7 Owen Mumford
5.7.1 Owen Mumford Company Information
5.7.2 Owen Mumford Description, Business Overview
5.7.3 Owen Mumford Diabetes Injection Pens Products Offered
5.7.4 Owen Mumford Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Owen Mumford Diabetes Injection Pens Sales by Product in 2024
5.7.6 Owen Mumford Diabetes Injection Pens Sales by Application in 2024
5.7.7 Owen Mumford Diabetes Injection Pens Sales by Geographic Area in 2024
5.7.8 Owen Mumford Recent Developments
5.8 Ganlee
5.8.1 Ganlee Company Information
5.8.2 Ganlee Description, Business Overview
5.8.3 Ganlee Diabetes Injection Pens Products Offered
5.8.4 Ganlee Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Ganlee Diabetes Injection Pens Sales by Product in 2024
5.8.6 Ganlee Diabetes Injection Pens Sales by Application in 2024
5.8.7 Ganlee Diabetes Injection Pens Sales by Geographic Area in 2024
5.8.8 Ganlee Recent Developments
5.9 Delfu
5.9.1 Delfu Company Information
5.9.2 Delfu Description, Business Overview
5.9.3 Delfu Diabetes Injection Pens Products Offered
5.9.4 Delfu Diabetes Injection Pens Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Delfu Diabetes Injection Pens Sales by Product in 2024
5.9.6 Delfu Diabetes Injection Pens Sales by Application in 2024
5.9.7 Delfu Diabetes Injection Pens Sales by Geographic Area in 2024
5.9.8 Delfu Recent Developments
6 North America
6.1 North America Diabetes Injection Pens Market Size YoY Growth 2020-2031
6.2 North America Diabetes Injection Pens Market Facts & Figures by Country
6.2.1 North America Diabetes Injection Pens Sales by Country (2020-2031)
6.2.2 North America Diabetes Injection Pens Revenue by Country (2020-2031)
6.3 North America Diabetes Injection Pens Sales by Type (2020-2025)
6.4 North America Diabetes Injection Pens Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Diabetes Injection Pens Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Diabetes Injection Pens Market Facts & Figures by Region
7.2.1 Asia-Pacific Diabetes Injection Pens Sales by Region (2020-2031)
7.2.2 Asia-Pacific Diabetes Injection Pens Revenue by Region (2020-2031)
7.3 Asia-Pacific Diabetes Injection Pens Sales by Type (2020-2025)
7.4 Asia-Pacific Diabetes Injection Pens Sales by Application (2020-2025)
8 Europe
8.1 Europe Diabetes Injection Pens Market Size YoY Growth 2020-2031
8.2 Europe Diabetes Injection Pens Market Facts & Figures by Country
8.2.1 Europe Diabetes Injection Pens Sales by Country (2020-2031)
8.2.2 Europe Diabetes Injection Pens Revenue by Country (2020-2031)
8.3 Europe Diabetes Injection Pens Sales by Type (2020-2025)
8.4 Europe Diabetes Injection Pens Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Diabetes Injection Pens Market Size YoY Growth 2020-2031
9.2 Latin America Diabetes Injection Pens Market Facts & Figures by Country
9.2.1 Latin America Diabetes Injection Pens Sales by Country (2020-2031)
9.2.2 Latin America Diabetes Injection Pens Revenue by Country (2020-2031)
9.3 Latin America Diabetes Injection Pens Sales by Type (2020-2025)
9.4 Latin America Diabetes Injection Pens Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Diabetes Injection Pens Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Diabetes Injection Pens Market Facts & Figures by Country
10.2.1 Middle East and Africa Diabetes Injection Pens Sales by Country (2020-2031)
10.2.2 Middle East and Africa Diabetes Injection Pens Revenue by Country (2020-2031)
10.3 Middle East and Africa Diabetes Injection Pens Sales by Type (2020-2025)
10.4 Middle East and Africa Diabetes Injection Pens Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Diabetes Injection Pens Supply Chain Analysis
11.2 Diabetes Injection Pens Key Raw Materials and Upstream Suppliers
11.3 Diabetes Injection Pens Clients Analysis
11.4 Diabetes Injection Pens Sales Channel and Sales Model Analysis
11.4.1 Diabetes Injection Pens Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Diabetes Injection Pens Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Diabetes Injection Pens Distributors
12 Diabetes Injection Pens Market Dynamics
12.1 Diabetes Injection Pens Industry Trends
12.2 Diabetes Injection Pens Market Drivers
12.3 Diabetes Injection Pens Market Challenges
12.4 Diabetes Injection Pens Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Diabetes Injection Pens Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Diabetes Injection Pens Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Diabetes Injection Pens Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Diabetes Injection Pens Sales by Region (2020-2025) & (M Units)
 Table 5. Global Diabetes Injection Pens Sales Forecast by Region (2026-2031) & (M Units)
 Table 6. Global Diabetes Injection Pens Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Diabetes Injection Pens Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Diabetes Injection Pens Sales Volume by Type (2020-2025) & (M Units)
 Table 9. Global Diabetes Injection Pens Sales Volume by Type (2026-2031) & (M Units)
 Table 10. Global Diabetes Injection Pens Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Diabetes Injection Pens Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Diabetes Injection Pens Sales Volume by Application (2020-2025) & (M Units)
 Table 13. Global Diabetes Injection Pens Sales Volume by Application (2026-2031) & (M Units)
 Table 14. Global Diabetes Injection Pens Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Diabetes Injection Pens Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Diabetes Injection Pens Sales by Manufacturer (2020-2025) & (M Units)
 Table 17. Global Diabetes Injection Pens Sales Share by Manufacturer (2020-2025)
 Table 18. Diabetes Injection Pens Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Diabetes Injection Pens Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Diabetes Injection Pens Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Diabetes Injection Pens Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Diabetes Injection Pens Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Diabetes Injection Pens by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Injection Pens as of 2024)
 Table 24. Diabetes Injection Pens Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Diabetes Injection Pens Market
 Table 26. Manufacturers Diabetes Injection Pens Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Novo Nordisk Company Information
 Table 29. Novo Nordisk Description and Business Overview
 Table 30. Novo Nordisk Diabetes Injection Pens Product
 Table 31. Novo Nordisk Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Novo Nordisk Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 33. Novo Nordisk Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 34. Novo Nordisk Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 35. Novo Nordisk Recent Developments
 Table 36. Eli Lilly Company Information
 Table 37. Eli Lilly Description and Business Overview
 Table 38. Eli Lilly Diabetes Injection Pens Product
 Table 39. Eli Lilly Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Eli Lilly Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 41. Eli Lilly Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 42. Eli Lilly Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 43. Eli Lilly Recent Developments
 Table 44. Sanofi Company Information
 Table 45. Sanofi Description and Business Overview
 Table 46. Sanofi Diabetes Injection Pens Product
 Table 47. Sanofi Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Sanofi Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 49. Sanofi Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 50. Sanofi Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 51. Sanofi Recent Developments
 Table 52. BD Company Information
 Table 53. BD Description and Business Overview
 Table 54. BD Diabetes Injection Pens Product
 Table 55. BD Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. BD Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 57. BD Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 58. BD Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 59. BD Recent Developments
 Table 60. Ypsomed Holding Company Information
 Table 61. Ypsomed Holding Description and Business Overview
 Table 62. Ypsomed Holding Diabetes Injection Pens Product
 Table 63. Ypsomed Holding Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Ypsomed Holding Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 65. Ypsomed Holding Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 66. Ypsomed Holding Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 67. Ypsomed Holding Recent Developments
 Table 68. Dongbao Company Information
 Table 69. Dongbao Description and Business Overview
 Table 70. Dongbao Diabetes Injection Pens Product
 Table 71. Dongbao Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Dongbao Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 73. Dongbao Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 74. Dongbao Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 75. Dongbao Recent Developments
 Table 76. Owen Mumford Company Information
 Table 77. Owen Mumford Description and Business Overview
 Table 78. Owen Mumford Diabetes Injection Pens Product
 Table 79. Owen Mumford Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Owen Mumford Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 81. Owen Mumford Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 82. Owen Mumford Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 83. Owen Mumford Recent Developments
 Table 84. Ganlee Company Information
 Table 85. Ganlee Description and Business Overview
 Table 86. Ganlee Diabetes Injection Pens Product
 Table 87. Ganlee Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Ganlee Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 89. Ganlee Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 90. Ganlee Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 91. Ganlee Recent Developments
 Table 92. Delfu Company Information
 Table 93. Delfu Description and Business Overview
 Table 94. Delfu Diabetes Injection Pens Product
 Table 95. Delfu Diabetes Injection Pens Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Delfu Sales Proportion of Diabetes Injection Pens by Product in 2024
 Table 97. Delfu Sales Proportion of Diabetes Injection Pens by Application in 2024
 Table 98. Delfu Sales Proportion of Diabetes Injection Pens by Geographic Area in 2024
 Table 99. Delfu Recent Developments
 Table 100. North America Diabetes Injection Pens Sales by Country (2020-2025) & (M Units)
 Table 101. North America Diabetes Injection Pens Sales by Country (2026-2031) & (M Units)
 Table 102. North America Diabetes Injection Pens Revenue by Country (2020-2025) & (US$ Million)
 Table 103. North America Diabetes Injection Pens Revenue by Country (2026-2031) & (US$ Million)
 Table 104. North America Diabetes Injection Pens Sales by Type (2020-2025) & (M Units)
 Table 105. North America Diabetes Injection Pens Sales by Application (2020-2025) & (M Units)
 Table 106. Asia-Pacific Diabetes Injection Pens Sales by Region (2020-2025) & (M Units)
 Table 107. Asia-Pacific Diabetes Injection Pens Sales by Region (2026-2031) & (M Units)
 Table 108. Asia-Pacific Diabetes Injection Pens Revenue by Region (2020-2025) & (US$ Million)
 Table 109. Asia-Pacific Diabetes Injection Pens Revenue by Region (2026-2031) & (US$ Million)
 Table 110. Asia-Pacific Diabetes Injection Pens Sales by Type (2020-2025) & (M Units)
 Table 111. Asia-Pacific Diabetes Injection Pens Sales by Application (2020-2025) & (M Units)
 Table 112. Europe Diabetes Injection Pens Sales by Country (2020-2025) & (M Units)
 Table 113. Europe Diabetes Injection Pens Sales by Country (2026-2031) & (M Units)
 Table 114. Europe Diabetes Injection Pens Revenue by Country (2020-2025) & (US$ Million)
 Table 115. Europe Diabetes Injection Pens Revenue by Country (2026-2031) & (US$ Million)
 Table 116. Europe Diabetes Injection Pens Sales by Type (2020-2025) & (M Units)
 Table 117. Europe Diabetes Injection Pens Sales by Application (2020-2025) & (M Units)
 Table 118. Latin America Diabetes Injection Pens Sales by Country (2020-2025) & (M Units)
 Table 119. Latin America Diabetes Injection Pens Sales by Country (2026-2031) & (M Units)
 Table 120. Latin America Diabetes Injection Pens Revenue by Country (2020-2025) & (US$ Million)
 Table 121. Latin America Diabetes Injection Pens Revenue by Country (2026-2031) & (US$ Million)
 Table 122. Latin America Diabetes Injection Pens Sales by Type (2020-2025) & (M Units)
 Table 123. Latin America Diabetes Injection Pens Sales by Application (2020-2025) & (M Units)
 Table 124. Middle East and Africa Diabetes Injection Pens Sales by Country (2020-2025) & (M Units)
 Table 125. Middle East and Africa Diabetes Injection Pens Sales by Country (2026-2031) & (M Units)
 Table 126. Middle East and Africa Diabetes Injection Pens Revenue by Country (2020-2025) & (US$ Million)
 Table 127. Middle East and Africa Diabetes Injection Pens Revenue by Country (2026-2031) & (US$ Million)
 Table 128. Middle East and Africa Diabetes Injection Pens Sales by Type (2020-2025) & (M Units)
 Table 129. Middle East and Africa Diabetes Injection Pens Sales by Application (2020-2025) & (M Units)
 Table 130. Diabetes Injection Pens Key Raw Materials, Industry Status and Trend
 Table 131. Diabetes Injection Pens Key Raw Materials and Upstream Suppliers
 Table 132. Diabetes Injection Pens Clients Status and Trend
 Table 133. Diabetes Injection Pens Typical Clients
 Table 134. Diabetes Injection Pens Distributors
 Table 135. Diabetes Injection Pens Market Trends
 Table 136. Diabetes Injection Pens Market Drivers
 Table 137. Diabetes Injection Pens Market Challenges
 Table 138. Diabetes Injection Pens Market Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Diabetes Injection Pens Product Picture
 Figure 2. Global Diabetes Injection Pens Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Diabetes Injection Pens Sales Market Share by Type in 2024 & 2031
 Figure 4. Reusable Insulin Pens Product Picture
 Figure 5. Disposable Insulin Pens Product Picture
 Figure 6. Global Diabetes Injection Pens Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Diabetes Injection Pens Sales Market Share by Application in 2024 & 2031
 Figure 8. Hospital & Clinic
 Figure 9. Retail Pharmacy
 Figure 10. Online Sales
 Figure 11. Diabetes Injection Pens Report Years Considered
 Figure 12. Global Diabetes Injection Pens Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Diabetes Injection Pens Market Size 2020-2031 (US$ Million)
 Figure 14. Global Diabetes Injection Pens Sales 2020-2031 (M Units)
 Figure 15. Global Diabetes Injection Pens Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Diabetes Injection Pens Revenue Market Share by Region (2020-2031)
 Figure 17. Global Diabetes Injection Pens Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Diabetes Injection Pens Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Diabetes Injection Pens Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 20. Global Diabetes Injection Pens Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Diabetes Injection Pens Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Diabetes Injection Pens Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 23. Reusable Insulin Pens of Diabetes Injection Pens Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Disposable Insulin Pens of Diabetes Injection Pens Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Diabetes Injection Pens Sales Share by Manufacturer in 2024
 Figure 26. Diabetes Injection Pens Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Reusable Insulin Pens Market Sales Proportion by Manufacturer in 2024
 Figure 28. Disposable Insulin Pens Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Diabetes Injection Pens Revenue 2020-2031 (US$ Million)
 Figure 30. North America Diabetes Injection Pens Sales Market Share by Type (2020-2025)
 Figure 31. North America Diabetes Injection Pens Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Diabetes Injection Pens Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Diabetes Injection Pens Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Diabetes Injection Pens Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Diabetes Injection Pens Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Diabetes Injection Pens Sales Market Share by Application (2020-2025)
 Figure 37. Europe Diabetes Injection Pens Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Diabetes Injection Pens Sales Market Share by Country (2020-2031)
 Figure 39. Europe Diabetes Injection Pens Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Diabetes Injection Pens Sales Market Share by Type (2020-2025)
 Figure 41. Europe Diabetes Injection Pens Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Diabetes Injection Pens Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Diabetes Injection Pens Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Diabetes Injection Pens Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Diabetes Injection Pens Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Diabetes Injection Pens Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Diabetes Injection Pens Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Diabetes Injection Pens Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Diabetes Injection Pens Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Diabetes Injection Pens Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Diabetes Injection Pens Sales Market Share by Application (2020-2025)
 Figure 52. Diabetes Injection Pens Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Diabetes Injection Pens Raw Materials by Region in 2024
 Figure 54. Diabetes Injection Pens Distribution Channels
 Figure 55. Global Diabetes Injection Pens Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Diabetes Injection Pens Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc